The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months. (New York Daily News) COVID-19 vaccination in the United StatesCOVID-19 pandemic in the United StatesCOVID-19 pandemic link embed save